Catalyst Wire Dossier Catalyst Wire Dossier

OIF/β-TCP

· BioGend Therapeutics Co.Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OIF/β-TCP, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting [NA]

See pricing